OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
July 18, 2022
US legislators are devising strategies ahead of the reauthorization deadline for the FDA User Fee legislation.
Royalty Pharma is paying $1.6 billion for the royalty rights to Trelegy Ellipta, a treatment for COPD and asthma.
FDA has granted an Emergency Use Authorization to Novavax’s COVID-19 vaccine.
The European Medicines Agency guidance highlights key principles and examples of good practices to prevent and manage shortages of human medicines.
Vertex’s $320 million acquisition of ViaCyte will give the company complementary capabilities for its Type 1 diabetes therapy program.
July 15, 2022
Exhibitors display innovations for parenteral and solid dose products.
July 14, 2022
Application for OTC contraceptive highlights efforts to broaden access to medicines.
July 13, 2022
WHO’s Science Council released a report calling for a collective effort to accelerate global access to genomics.
Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.
Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.